Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Limited Metastatic Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03179917
What this trial is testing

Pembrolizumab and Involved Site Radiation Therapy for Early Stage Relapsed or Primary Refractory Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Memorial Sloan Kettering Cancer Center 22
Not applicableUnknownNCT00079248
What this trial is testing

Hormone Replacement Therapy in Relieving Menopausal Symptoms in Postmenopausal Women With Previous Stage I or Stage II Breast Cancer

Who this might be right for
Breast CancerHot FlashesMenopausal Symptoms+1 more
Institute of Cancer Research, United Kingdom
Not applicableNot Yet RecruitingNCT07514078
What this trial is testing

Evaluation of Laparoscopic Staging Versus Staging Laparotomy for Early Stage Endometrial Cancer

Who this might be right for
Treatment Endometrial Cancer
Ain Shams Maternity Hospital 30
Not applicableStudy completedNCT00001668
What this trial is testing

Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors

Who this might be right for
DeafnessKidney DiseasesKidney Neoplasms+2 more
National Institute of Neurological Disorders and Stroke (NINDS) 75
Not applicableStudy completedNCT03401840
What this trial is testing

STEREO-POSTOP 01 (PostOperative Hypofractionated Stereotactic Body Radiotherapy ) - GORTEC 2017-03

Who this might be right for
Head and Neck Neoplasms
Centre Jean Perrin 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT03573648
What this trial is testing

Neoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 33
Not applicableStudy completedNCT01290835
What this trial is testing

Conformal Partial Breast Irradiation With CyberKnife After Resection for Early Stage Breast Cancer

Who this might be right for
Breast Cancer
Essentia Health 20
Large-scale testing (Phase 3)Study completedNCT00144989
What this trial is testing

A Study Comparing Irinotecan and Cisplatin (IP) With Etoposide and Cisplatin (EP) Following EP/TRT for LD-SCLC

Who this might be right for
Small-Cell-Lung Cancer
Haruhiko Fukuda 281
Not applicableNot Yet RecruitingNCT06035068
What this trial is testing

SLN Mapping and ICG Dye for Vulvar Cancer

Who this might be right for
Vulva Cancer
Tufts Medical Center 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07781449
What this trial is testing

Topical JAK-Inhibition of Early-Stage CTCL

Who this might be right for
Mycosis FungoidesCutaneous T-cell Lymphoma
Aarhus University Hospital 15
Large-scale testing (Phase 3)Ended earlyNCT05418673
What this trial is testing

Assess if BIIB122 Tablets Are Safe and Can Slow Worsening of Early-Stage Parkinson's Disease in Participants With Specific LRRK2 Genetic Variants Between the Ages of 30 and 80 Using the Movement Disorder Society-Unified Parkinson's Disease Rating Scale

Who this might be right for
Parkinson Disease
Biogen 7
Early research (Phase 1)Looking for participantsNCT06430541
What this trial is testing

Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence

Who this might be right for
Breast CancerOvarian Cancer
University of Colorado, Denver 20
Not applicableStudy completedNCT03925103
What this trial is testing

Assessment of Ergonomics in 3D vs 2D Thoracoscopic Lobectomy

Who this might be right for
Early Stage Non-small-cell Lung Cancer (Stage 1-2)
University of Rome Tor Vergata 70
Not applicableUnknownNCT03870802
What this trial is testing

MACSSI (MAstectomie Cellules Souches Surveillance Immunitaire)

Who this might be right for
Breast Cancer
Centre Leon Berard 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT02592083
What this trial is testing

Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive Tumors

Who this might be right for
Early-Stage Breast CarcinomaHormone Receptor Positive Tumor
Thomas Hatschek 10
Testing effectiveness (Phase 2)Study completedNCT00470054
What this trial is testing

Dasatinib in Treating Patients With Relapsed Small Cell Lung Cancer

Who this might be right for
Extensive Stage Small Cell Lung CancerLimited Stage Small Cell Lung CancerRecurrent Small Cell Lung Cancer
National Cancer Institute (NCI) 44
Not applicableEnded earlyNCT04376502
What this trial is testing

Immune Checkpoint Inhibitor and MR-guided SBRT for Limited Progressive Metastatic Carcinoma.

Who this might be right for
Metastatic Carcinoma
Baptist Health South Florida 12
Not applicableNot Yet RecruitingNCT07597642
What this trial is testing

ON-treatment Single-cell Analysis for the Identification of Early Tumor Response Biomarkers on Prospective Collected Serial Tumor Biopsies in Triple Negative Breast Cancer Patient During Standard Neoadjuvant Chemo-immunotherapy

Who this might be right for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
IRCCS San Raffaele 55
Not applicableUnknownNCT03821454
What this trial is testing

Capecitabine in the Treatment of Breast Cancer With Low-hormone Receptor Expression After Neoadjuvant Chemotherapy

Who this might be right for
Breast Cancer
Zhejiang Cancer Hospital 50
Testing effectiveness (Phase 2)Study completedNCT00436566
What this trial is testing

Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery

Who this might be right for
Breast CancerCardiac Toxicity
Mayo Clinic 122
Next Page